- Home
- GANX vs AGMH Comparison
GANX vs AGMH Comparison
Compare GANX & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GANX
- AGMH
- Stock Information
- Founded
- GANX 2017
- AGMH 2015
- Country
- GANX United States
- AGMH Hong Kong
- Employees
- GANX N/A
- AGMH N/A
- Industry
- GANX Biotechnology: Pharmaceutical Preparations
- AGMH EDP Services
- Sector
- GANX Health Care
- AGMH Technology
- Exchange
- GANX Nasdaq
- AGMH Nasdaq
- Market Cap
- GANX 53.8M
- AGMH 3.5M
- IPO Year
- GANX 2021
- AGMH 2018
- Fundamental
- Price
- GANX $1.77
- AGMH $2.62
- Analyst Decision
- GANX Strong Buy
- AGMH
- Analyst Count
- GANX 5
- AGMH 0
- Target Price
- GANX $8.20
- AGMH N/A
- AVG Volume (30 Days)
- GANX 324.3K
- AGMH 575.4K
- Earning Date
- GANX 08-07-2025
- AGMH 07-11-2025
- Dividend Yield
- GANX N/A
- AGMH N/A
- EPS Growth
- GANX N/A
- AGMH N/A
- EPS
- GANX N/A
- AGMH 6.43
- Revenue
- GANX N/A
- AGMH $32,044,575.00
- Revenue This Year
- GANX N/A
- AGMH N/A
- Revenue Next Year
- GANX N/A
- AGMH N/A
- P/E Ratio
- GANX N/A
- AGMH $0.37
- Revenue Growth
- GANX N/A
- AGMH N/A
- 52 Week Low
- GANX $0.89
- AGMH $1.09
- 52 Week High
- GANX $3.19
- AGMH $109.50
- Technical
- Relative Strength Index (RSI)
- GANX 44.01
- AGMH 46.10
- Support Level
- GANX $1.55
- AGMH $2.16
- Resistance Level
- GANX $2.04
- AGMH $2.59
- Average True Range (ATR)
- GANX 0.16
- AGMH 0.33
- MACD
- GANX -0.02
- AGMH 0.07
- Stochastic Oscillator
- GANX 28.34
- AGMH 77.05
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.
About AGMH AGM Group Holdings Inc.
AGM Group Holdings Inc is an investment holding company. The company focuses on blockchain-oriented ASIC chip design; high-end crypto miner production and fintech technology software service. It generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.